Jiying Technology Co., Ltd.

Jiying Technology Co., Ltd. (芨影科技) is a Hong Kong-based medical artificial intelligence company founded in May 2019 and headquartered at Hong Kong Science Park. The company focuses on the intersection of clinical medicine, artificial intelligence, and life sciences, aiming to develop innovative medical AI products that assist physicians in improving diagnostic efficiency and safeguarding patient health. Its stated mission is to maintain public health and medical equity by creating innovative preventive medical technologies that are accessible and affordable to everyone worldwide. The company was jointly founded by medical experts, AI specialists, biology experts, and experienced managers. Its R&D team is highly educated, with 100% of researchers holding master's degrees or above, and 85% holding doctoral degrees in relevant fields. Since its establishment, Jiying Technology has applied for three invention patents and one utility model patent. Jiying Technology's product portfolio includes an AI recognition system for early gastrointestinal cancer detected via gastroscopy and colonoscopy, a 3D AI-assisted diagnosis system for severe acute pancreatitis based on CT imaging, a portable AI remote diagnosis and treatment system for vital signs, an AI recognition and warning system for atrial fibrillation, and a traditional Chinese medicine health and wellness system. The company has established partnerships with enterprises, medical institutions, and universities in mainland China to jointly build a medical ecosystem chain for specialized fields and provide interdisciplinary life and health protection solutions. The company has received numerous awards and recognitions, including the National Finals Excellence Award in the 2020 Ministry of Industry and Information Technology Epidemic Prevention and Control Special Competition, third prize at the 2021 "Luchuang Future" US Silicon Valley High-Tech Entrepreneurship Conference, Excellence Award at the 2021 Fourth People's Daily Content Technology Entrepreneurship Competition National Finals, Silver Award at the 2022 and 2023 Huawei Hunan Region Ascend World Computing Finals, the 2023 Hong Kong Pengcheng SME Youth Innovation and Entrepreneurship Special Award, and a 2023 Excellence Award jointly issued by UNESCO, the Hong Kong Innovation and Technology Commission, and the Hong Kong Quality Assurance Agency. The company has also participated in international exhibitions such as the 9.8 International Trade Fair hosted by the Ministry of Commerce and the 25th and 26th Macao MIF. Jiying Technology continues to advance its research, with recent publications in peer-reviewed journals such as the Journal of Computer-Aided Molecular Design and The Digestive and Liver Disease Journal. The company exhibited its Genoimage products at the Asian Medical Health Summit Forum.

Jiying Technology Co., Ltd. was established in May 2019 in Hong Kong, with its office located at Hong Kong Science Park, the third largest international innovation and technology park globally. The company was founded by a group of medical experts, artificial intelligence specialists, biology experts, and experienced business managers. Its core focus is on advanced technologies at the intersection of clinical medicine, artificial intelligence, and life sciences, with the aim of continuously developing innovative medical AI products for use in the healthcare field to help physicians improve diagnostic efficiency and protect patients' lives and health. Since its inception, the company has applied for three invention patents and one utility model patent. It has received numerous awards and recognitions, including the National Finals Excellence Award in the 2020 Ministry of Industry and Information Technology Epidemic Prevention and Control Special Competition; third prize at the 2021 "Luchuang Future" US Silicon Valley (All-US) High-Tech Entrepreneurship Conference; Excellence Award at the 2021 Fourth People's Daily Content Technology Entrepreneurship Competition National Finals; Silver Award at the 2022 and 2023 Huawei Hunan Region Ascend World Computing Finals; the 2023 Hong Kong Pengcheng SME Youth Innovation and Entrepreneurship Special Award; and a 2023 Excellence Award jointly issued by UNESCO, the Hong Kong Innovation and Technology Commission, and the Hong Kong Quality Assurance Agency. The company has also participated in international exhibitions such as the 9.8 International Trade Fair hosted by the Ministry of Commerce and the 25th and 26th Macao MIF. Jiying Technology has developed several AI-powered medical products, including a gastrointestinal endoscopy AI early cancer recognition system, a CT 3D AI-assisted diagnosis system for severe acute pancreatitis, a portable AI remote diagnosis and treatment system for vital signs, an atrial fibrillation AI recognition and warning system, and a traditional Chinese medicine health and wellness system. The company has established cooperative relationships with enterprises, medical institutions, and universities in mainland China to jointly build a medical ecosystem chain for specialized fields and provide interdisciplinary life and health protection solutions. In terms of research, Jiying Technology's work has been published in peer-reviewed journals. In September 2022, a study titled "A computer-aided diagnosis system using white-light endoscopy for the prediction of conventional adenoma with high grade dysplasia" was published in The Digestive and Liver Disease Journal. The study presented the ECRC CAD system, which achieved an accuracy of 90.5% in diagnosing high-grade dysplasia in internal validation and 88.2% in external validation, outperforming expert endoscopists. In January 2026, another article by the Jiying team was published in the Journal of Computer-Aided Molecular Design, titled "Unveiling structural dynamics and allosteric vulnerabilities in Klebsiella pneumoniae KPHS_11890: an integrated DRKG-MD study." The company also exhibited its Genoimage products at the Asian Medical Health Summit Forum.

• Company established in Hong Kong, office located at Hong Kong Science Park.

• Won National Finals Excellence Award in the Ministry of Industry and Information Technology Epidemic Prevention and Control Special Competition.

• Won third prize at the "Luchuang Future" US Silicon Valley High-Tech Entrepreneurship Conference and Excellence Award at the Fourth People's Daily Content Technology Entrepreneurship Competition National Finals.

• Research on ECRC CAD system published in The Digestive and Liver Disease Journal.

• Won Silver Award at Huawei Hunan Region Ascend World Computing Finals.

• Won Silver Award at Huawei Hunan Region Ascend World Computing Finals, Hong Kong Pengcheng SME Youth Innovation and Entrepreneurship Special Award, and Excellence Award jointly issued by UNESCO, Hong Kong Innovation and Technology Commission, and Hong Kong Quality Assurance Agency.

• Article published in Journal of Computer-Aided Molecular Design.

Developer of accessible and affordable preventive medical AI technologies for early cancer detection and critical care, building a medical ecosystem chain.

• Gastrointestinal endoscopy AI early cancer recognition system

  Built on large real-world data, with average single-machine accuracy of 99.078%, average IoU 92%, and time 0.16 seconds, while providing high-risk or low-risk early cancer classification.

• CT 3D AI-assisted diagnosis system for severe acute pancreatitis

  Rapidly and objectively scores the degree of pancreatic damage, improving physician diagnostic efficiency and providing effective life protection for patients. Helps physicians provide multi-angle image reading, focusing on every detail, and offers high-value auxiliary diagnostic decisions.

• Portable AI remote diagnosis and treatment system for vital signs

  Can detect breath sounds and heart sounds. AI detects pathological sounds of respiratory diseases such as asthma, pneumonia, COPD, bronchitis; heart sounds of cardiovascular diseases such as valvular disease; and bowel sounds of the digestive system. The audio can be recorded, played back, and generate audio waveforms, suitable for remote consultation and teaching.

• Atrial fibrillation AI recognition and warning system

• Traditional Chinese medicine health and wellness system

  Intelligent Q&A robot for traditional Chinese medicine health and rehabilitation: early cancer auxiliary intervention, registration guidance and AI registration, common and frequent disease health care assistance, cancer health knowledge promotion, early cancer post-diagnosis medical order supervision, early cancer basic health information recording, medication instruction guidance.

1. 1JIYING TECHNOLOGY CO., LTD. Official Websitegenoimage.com
2. 2芨影研究在“The Digestive and Liver Disease Journal"刊登genoimage.com
3. 3芨影科技参展亚洲医疗健康高峰论坛genoimage.com
4. 4Wikidata: Jiying Technology Co., Ltd (China)wikidata.org